Can adenoidal hypertrophy be treated with intranasal steroids?

Marco Berlucchi1, Michele Sessa

  • 1Department of Pediatric Otorhinolaryngology, Spedali Civili, Brescia, Italy. marco.berlucchi@tin.it

Insights

Adenoidal hypertrophy, a common pediatric issue, causes nasal obstruction and sleep problems. This review explores conservative treatments like nasal steroids as alternatives to adenoidectomy, addressing its surgical drawbacks.

Area of Science:

  • Pediatric Otolaryngology
  • Sleep Medicine
  • Rhinology

Background:

  • Adenoidal hypertrophy is a prevalent pediatric condition.
  • Symptoms include nasal obstruction, snoring, and sleep apnea.
  • Adenoidectomy is the standard surgical treatment, but has potential complications.

Purpose of the Study:

  • To review the literature on conservative treatments for adenoidal hypertrophy.
  • To evaluate the efficacy of topical nasal steroids.
  • To discuss alternatives to surgical adenoidectomy.

Main Methods:

  • Literature review of conservative management strategies.
  • Inclusion of personal clinical experience.
  • Focus on topical nasal steroids and their impact on symptoms and adenoid size.

Main Results:

  • Topical nasal steroids show promise in reducing adenoidal hypertrophy symptoms.
  • Conservative treatments may offer an alternative to surgery for some patients.
  • Further research is needed to establish optimal conservative treatment protocols.

Conclusions:

  • Conservative management, particularly topical nasal steroids, presents a viable alternative to adenoidectomy.
  • Addressing adenoidal hypertrophy with non-surgical options can mitigate surgical risks.
  • Personal experience supports the use of conservative approaches in managing pediatric adenoidal hypertrophy.

Related Concept Videos

Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in various...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...